Media Reports

A Breakthrough in Transfusion Medicine — MetaTech and Megakaryon Launch Artificial Platelet Project in Taiwan

Hsiu-Lei Hung Appears as Brand Ambassador — MetaTech Biomed’s M Cell Ushering in a New Era of Safe Autologous Regenerative Medicine

MetaTech and CM Plus Establish Strategic Partnership to Build “AI Katana” Platform for Biotech Market Expansion in Japan and Asia

TOKYO/TAIPEI - October 13, 2025 - MetaTech (AP) Inc. (TWSE: 3224), a leading Taiwanese biotech AI technology company, and CM Plus, a multinational enterprise specializing in high-standard engineering management and regulatory compliance (headquartered in Singapore and Yokohama, Japan), have signed a Memorandum of Understanding (MOU) to jointly build a new cross-border platform for accelerating biotech product market entry between Taiwan and Japan.

MetaTech Group Visits Expo 2025 Osaka, Showcasing Its Commitment to iPSC Technology Development

Cutting-Edge Stem Cell Technology Captures the Heart of Asian King – iPSC Family Stem Cell Storage Service